Those of us who are aggressive on Brilacidin, need
Post# of 72445
(Total Views: 669)
Posted On: 04/30/2020 11:57:40 AM
Those of us who are aggressive on Brilacidin, need to get active and get the word out to anyone in authority that you hear about on the news.
I sent an email, yesterday, to a few Sr directors under Dr.Fauci at the NIH.
I explained what Brilacidin is and why it may be one of the best Therapeutic solutions. I also gave him Innovation Pharmaceuticals web address and invited them to get more info on the company.
I closed with the following paragraph in order to get the support of someone in authority.
"My concern is this. Brilacidin, as potentially the best therapeutic solution for Covid-19 and other diseases, is going up against the politically influential, large pharmaceutical companies. Consequently, because it comes from a small company, it may just get pushed aside and ignored by the “system” unless someone in authority prevents that from happening."
One director was gracious enough to reply last evening.
He thanked me for the email and my comments on Brilacidin. He said he passed my email onto those looking at novel therapeutic approaches.
I sent an email, yesterday, to a few Sr directors under Dr.Fauci at the NIH.
I explained what Brilacidin is and why it may be one of the best Therapeutic solutions. I also gave him Innovation Pharmaceuticals web address and invited them to get more info on the company.
I closed with the following paragraph in order to get the support of someone in authority.
"My concern is this. Brilacidin, as potentially the best therapeutic solution for Covid-19 and other diseases, is going up against the politically influential, large pharmaceutical companies. Consequently, because it comes from a small company, it may just get pushed aside and ignored by the “system” unless someone in authority prevents that from happening."
One director was gracious enough to reply last evening.
He thanked me for the email and my comments on Brilacidin. He said he passed my email onto those looking at novel therapeutic approaches.
(11)
(1)